Nanobiotix S.A. (NBTX)
3.31
-0.25 (-7.02%)
At close: Mar 04, 2025, 11:45 AM
Nanobiotix S.A. Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Cash & Equivalents | 75.28M | 41.39M | 83.92M | 119.15M | 35.09M | 36.2M | 47.21M | 21.06M | 17M | 32.99M | 5M | 12.36M | 898.52K |
| Short-Term Investments | n/a | 2.81M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | 98K | 105K | 131K | 176K | 272.93K | 242.22K | 218.12K | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 443K | 291K | 421K | -1K | -1K | 382K | -1 | -1 | 1.00 | 247.35K | 68.14K | 68.6K | 63.16K |
| Receivables | 2.97M | 101K | 6.93M | 3.88M | 11K | 25K | 169K | 5.21K | 80.02K | 1.64K | 894.00 | 1.34K | 1.35M |
| Inventory | 200K | 2.98M | -3.04M | -40.32M | 2.67M | 1.09M | -4.9M | -5.03M | 1.21M | 473.94K | 199.54K | -1.07M | 87.81K |
| Other Current Assets | 9.09M | 10.87M | 2.21M | 2.22M | 11.02M | 6.42M | 5.73M | 5.83M | 5.86M | 2.52M | 1.89M | 107.01K | -1 |
| Total Current Assets | 87.34M | 52.36M | 93.06M | 125.25M | 46.13M | 42.65M | 53.11M | 26.89M | 22.95M | 35.5M | 6.89M | 13.54M | 2.33M |
| Property-Plant & Equipment | 6.11M | 7.12M | 8.19M | 8.26M | 9.39M | 2.88M | 2.99M | 2.43M | 2.43M | 1.29M | 467.73K | 416.13K | 510.79K |
| Goodwill & Intangibles | 8K | 1K | 4K | 21K | 163K | 102K | 135.97K | 4.45K | 7.53K | 9.94K | 9.07K | n/a | 6.51K |
| Total Long-Term Assets | 6.56M | 7.41M | 8.71M | 8.78M | 10.08M | 3.54M | 4.36M | 3.51M | 3.47M | 1.55M | 544.95K | 484.73K | 580.46K |
| Total Assets | 93.9M | 59.77M | 101.77M | 134.03M | 56.2M | 46.2M | 57.47M | 30.4M | 26.42M | 37.05M | 7.44M | 14.02M | 2.91M |
| Account Payables | 6.7M | 4M | 5M | 5.57M | 6.15M | 4.54M | 5.14M | 4.37M | 3.59M | 2.23M | 1.35M | 279.36K | 399.82K |
| Deferred Revenue | n/a | 16.57M | 16.52M | 8.59M | 7.11M | 93K | 2.96M | 2.23M | 1.79M | 1.43M | 1.04M | 1.52M | 719.35K |
| Short-Term Debt | 5.02M | 4.56M | 8.2M | 4.87M | 1.09M | 407K | 770K | 1.08M | -718.38K | -1.11M | -809.2K | 360.31K | 295.44K |
| Other Current Liabilities | 30.78M | 22.78M | 18.57M | 8.31M | 6.89M | 6.29M | 3.21M | 387.54K | -925.75K | 352.11K | 595.62K | 1.48M | 717.62K |
| Total Current Liabilities | 49.87M | 37.94M | 36.84M | 19.04M | 14.35M | 11.6M | 9.35M | 8.25M | 7.1M | 4.42M | 3.28M | 2.16M | 1.41M |
| Long-Term Debt | 45.54M | 48.61M | 37.82M | 44.11M | 43.44M | 20.02M | 3.75M | 4.58M | 3.53M | 2M | 875.17K | 1.07M | 526.77K |
| Other Long-Term Liabilities | 325K | 270K | 318K | 414K | 332K | 334K | 446.27K | 175.21K | 173.91K | 312.33K | 99.77K | 95.37K | 46.41K |
| Total Long-Term Liabilities | 45.87M | 48.88M | 38.13M | 44.52M | 43.77M | 20.36M | 4.19M | 4.76M | 3.7M | 2.31M | 974.93K | 1.17M | 573.18K |
| Total Liabilities | 95.74M | 86.81M | 74.98M | 63.56M | 58.11M | 31.95M | 13.54M | 13M | 10.81M | 6.74M | 4.26M | 3.33M | 1.99M |
| Total Debt | 50.56M | 53.17M | 46.02M | 48.98M | 44.53M | 20.52M | 4.73M | 5.67M | 4.6M | 2.32M | 1.11M | 1.43M | 822.21K |
| Common Stock | 1.41M | 1.05M | 1.04M | 1.03M | 672K | 589K | 589K | 478.96K | 424.97K | 421.94K | 322.87K | 322.57K | 230.32K |
| Retained Earnings | -39.7M | -57.04M | -47M | -33.59M | -50.91M | -30.34M | -26.14M | -21.88M | -17M | -9.56M | -8.14M | -5.33M | -5.25M |
| Comprehensive Income | -276.07M | -226.58M | -182.82M | -152.51M | -104.64M | -78.68M | -54.28M | -35.44M | -20.36M | -12.32M | -4.33M | 385.57K | -9.66M |
| Shareholders Equity | -1.84M | -27.05M | 26.79M | 70.47M | -1.91M | 14.24M | 43.92M | 17.4M | 15.61M | 30.32M | 3.18M | 10.7M | 925.53K |
| Total Investments | n/a | 2.81M | 98K | 105K | 131K | 176K | 272.93K | 242.22K | 218.12K | n/a | n/a | n/a | n/a |